Concizumab news

All news on Concizumab (also known as Alhemo): plants, production capacities, investments and involved companies.

11 July 2026

Novo Nordisk: denecimig (Mim8) shows positive long-term Phase 3 FRONTIER4 results in haemophilia A

Interim FRONTIER4 data show consistent safety and efficacy of denecimig across weekly, biweekly and monthly dosing, with low injection-site reactions and high zero-bleed rates.

Who will be producing Concizumab in the future?

Find out with chemXplore Alpha

Learn more